GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Synthesis and Degradation of Ketone Bodies

pathways : Synthesis and Degradation of Ketone Bodies pathways:

Fullview (zoomIn)


Related Genes to "Synthesis and Degradation of Ketone Bodies" content :

preload


Related products :

Catalog number Product name Quantity
30-904 COIL is an integral component of Cajal bodies (also called coiled bodies). Cajal bodies are nuclear suborganelles of varying number and composition that are involved in the post-transcriptional modifi 0.05 mg
0021000500 METHYL-ISO-BUTYL KETONE 99 percent FOR SYNTHESIS, CAS: 108-10-1 5x500ML
0021002500 METHYL-ISO-BUTYL KETONE 99 percent FOR SYNTHESIS, CAS: 108-10-1 2x2,5LTR
002100200K METHYL-ISO-BUTYL KETONE 99 percent FOR SYNTHESIS, CAS: 108-10-1 200LTR
002100025K METHYL-ISO-BUTYL KETONE 99 percent FOR SYNTHESIS, CAS: 108-10-1 25LTR
0057500500 2-ACETYLTHIOPHENE 98 percent FOR SYNTHESIS (Methyl-2-Thienyl ketone), CAS: 88-15-3 500ML
0057500100 2-ACETYLTHIOPHENE 98 percent FOR SYNTHESIS (Methyl-2-Thienyl ketone), CAS: 88-15-3 3x100ML
orb82331 C. trachomatis D Elem. Bodies protein Chlamydia trachomatis D (UW-3_Cx Strain) Elementary Bodies is an infectious disease antigen_toxin. For research use only. 1 ml
29-213 SMN1 localizes to both the cytoplasm and the nucleus. Within the nucleus, the protein localizes to subnuclear bodies called gems which are found near coiled bodies containing high concentrations of sm 0.05 mg
30-937 ACSBG2 belongs to the ATP-dependent AMP-binding enzyme family, bubblegum subfamily.ACSBG2 mediates activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta- 0.05 mg
26-833 ACSBG2 belongs to the ATP-dependent AMP-binding enzyme family, bubblegum subfamily.ACSBG2 mediates activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta- 0.05 mg
20-272-191022 Basal Bodies of Cillia - Mouse monoclonal [LhS28] to Basal Bodies of Cillia Monoclonal 0.1 mg
EKBD-100 EnzyChrom™ Ketone Body Assay Kit, Quantitative determination of ketone body (acetoacetate and 3-hydroxybutyrate) in serum, plasma, urine etc at 340 nm 100Tests
30-956 Autophagy is the major intracellular degradation system delivering cytoplasmic components to lysosomes, and it accounts for degradation of most long-lived proteins and some organelles. Cytoplasmic con 0.05 mg
30-957 Autophagy is the major intracellular degradation system delivering cytoplasmic components to lysosomes, and it accounts for degradation of most long-lived proteins and some organelles. Cytoplasmic con 0.05 mg
EKBD-100 EnzyChrom™ Ketone Body Assay Kit, Quantitative determination of ketone body (acetoacetate and 3-hydroxybutyrate) in serum, plasma, urine etc at 340 nm. Procedure 30 min. Kit size 100 tests. Detectio 100tests
19437-26-4 Di_2_pyridyl ketone = Bis_(2_pyridyl)_keto Di_2_pyridyl ketone 1g
27-171 ERLIN2 plays an important role in the early steps of the endoplasmic reticulum-associated degradation (ERAD) pathway. It is involved in ITPR1 degradation by the ERAD pathway. 0.05 mg
31-050 MDM4 inhibits p53- and p73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. It inhibits degradation of MDM2. It can reverse MDM2-targeted degradation of p53 w 0.05 mg
31-051 MDM4 inhibits p53- and p73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. inhibits degradation of MDM2. It can reverse MDM2-targeted degradation of p53 whil 0.1 mg
5471-51-2 Raspberry ketone synthetic Raspberry Ketone synt 1g
5471-51-2 Raspberry ketone natural Raspberry ketone natur 1g
1453-52-7 dicyclopropyl ketone oxime dicyclopropyl ketone oxi 1g
38963-94-9 Raspberry Ketone _-D-Glucoside Raspberry Ketone _-D- 1g
GTX14373 Basal Bodies of Cillia 100 µg

Pathways :

WP101: Synthesis and Degradation of Ketone Bodies
WP1134: Synthesis and Degradation of Ketone Bodies
WP784: Synthesis and Degradation of Ketone Bodies
WP349: Synthesis and Degradation of Ketone Bodies
WP2316: PPAR signaling pathway
WP543: Synthesis and Degradation of Ketone Bodies
WP427: Synthesis and Degradation of Ketone Bodies
WP1015: Synthesis and Degradation of Ketone Bodies
WP311: Synthesis and Degradation of Ketone Bodies
WP1706: Synthesis and degradation of ketone bodies
WP898: Synthesis and Degradation of Ketone Bodies
WP333: Synthesis and Degradation of Ketone Bodies
WP1650: Fluorobenzoate degradation
WP281: Proteasome Degradation
WP546: Lactose degradation
WP1531: Vitamin D synthesis
WP181: P-cymene Degradation
WP374: Prostaglandin Synthesis and Regulation
WP972: Eicosanoid Synthesis
WP1612: 1,2-Dichloroethane degradation
WP1830: Insulin Synthesis and Processing
WP432: Asparagine degradation
WP995: Prostaglandin Synthesis and Regulation
WP1034: Acetylcholine Synthesis
WP1665: Limonene and pinene degradation

Related Genes :
[CYB At1g57620 T8L23.9] Transmembrane emp24 domain-containing protein p24delta4 (Protein CYTOPLASMIC BODIES) (p24 family protein delta1b) (p24delta1b) (p24 family protein delta4) (p24delta4)
[RREB1 FINB] Ras-responsive element-binding protein 1 (RREB-1) (Finger protein in nuclear bodies) (Raf-responsive zinc finger protein LZ321) (Zinc finger motif enhancer-binding protein 1) (Zep-1)
[Oamb oa1 CG3856] Octopamine receptor Oamb (Octopamine receptor in mushroom bodies)
[mbt CG18582] Serine/threonine-protein kinase PAK mbt (EC 2.7.11.1) (Protein mushroom bodies tiny) (p21-activated kinase-related protein)
[DOA1 UFD3 ZZZ4 YKL213C] Protein DOA1 (Degradation of alpha protein 1) (Ubiquitin fusion degradation protein 3)
[GLYI-11 GLX-I Os08g0191700 LOC_Os08g09250 OSJNBa0056O06.9-1] Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Allergen Glb33) (Glyoxalase I) (Glx I) (Glyoxylase I 11) (OsGLYI-11) (OsGLYI11) (Ketone-aldehyde mutase) (Methylglyoxalase) (PP33) (S-D-lactoylglutathione methylglyoxal lyase) (allergen Ory s Glyoxalase I)
[glo1 SPBC12C2.12c SPBC21D10.03c] Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)
[GLO1] Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)
[gloA b1651 JW1643] Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)
[Glo1] Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)
[Glo1] Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)
[FAP] Prolyl endopeptidase FAP (EC 3.4.21.26) (Dipeptidyl peptidase FAP) (EC 3.4.14.5) (Fibroblast activation protein alpha) (FAPalpha) (Gelatine degradation protease FAP) (EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease) (SIMP) (Surface-expressed protease) (Seprase) (Z-Pro-prolinal insensitive peptidase) (ZIP) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form (APCE) (EC 3.4.14.5) (EC 3.4.21.-) (EC 3.4.21.26)]
[FAP] Prolyl endopeptidase FAP (EC 3.4.21.26) (170 kDa melanoma membrane-bound gelatinase) (Dipeptidyl peptidase FAP) (EC 3.4.14.5) (Fibroblast activation protein alpha) (FAPalpha) (Gelatine degradation protease FAP) (EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease) (SIMP) (Surface-expressed protease) (Seprase) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form (APCE) (EC 3.4.14.5) (EC 3.4.21.-) (EC 3.4.21.26)]
[Fap] Prolyl endopeptidase FAP (EC 3.4.21.26) (Dipeptidyl peptidase FAP) (EC 3.4.14.5) (Fibroblast activation protein alpha) (FAPalpha) (Gelatine degradation protease FAP) (EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease) (SIMP) (Surface-expressed protease) (Seprase) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form (APCE) (EC 3.4.14.5) (EC 3.4.21.-) (EC 3.4.21.26)]
[GLXI] Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (GmGlyoxI) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)
[ACAT1 ACAT MAT] Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (T2)
[GLO1 YML004C YM9571.15C] Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)
[Hmgcl] Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase)
[HMGCL] Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase)
[Hmgcl] Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase)
[GLO1 QnpA-15219] Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)
[UFD1 UFD1L] Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1) (UB fusion protein 1)
[AKT2] RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta)
[HMGCLL1] 3-hydroxy-3-methylglutaryl-CoA lyase, cytoplasmic (EC 4.1.3.4) (3-hydroxy-3-methylglutaryl-CoA lyase-like protein 1) (Endoplasmic reticulum 3-hydroxy-3-methylglutaryl-CoA lyase) (er-cHL)
[] Monocyclic monoterpene ketone monooxygenase (MMKMO) (EC 1.14.13.105) (Baeyer-Villiger monooxygenase) (BVMO) (Fragment)
[ACAA2] 3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-) (EC 3.1.2.1) (EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase) (T1)
[Ufd1 Ufd1l] Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1 homolog) (UB fusion protein 1)
[] Genome polyprotein [Cleaved into: Protein VP0 (VP4-VP2); Protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Protein VP1-2A (VP1-pX); Capsid protein VP1 (P1D) (Virion protein 1); Assembly signal 2A (pX); Protein 2BC; Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3ABCD (P3); Protein 3ABC; Protein 3AB; Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD; Protease 3C (P3C) (EC 3.4.22.28) (Picornain 3C); RNA-directed RNA polymerase 3D-POL (P3D-POL) (EC 2.7.7.48)]
[Acat1] Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase)
[Acat1] Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase)

Bibliography :
[31904027] Efficacy and safety of D,L-3-hydroxybutyrate (D,L-3-HB) treatment in multiple acyl-CoA dehydrogenase deficiency.
[31900626] Comparison of the beta-hydroxybutyrate, glucose, and lactate concentrations derived from postmortem proton magnetic resonance spectroscopy and biochemical analysis for the diagnosis of fatal metabolic disorders.
[31899863] Differential network analysis reveals metabolic determinants associated with mortality in acute myocardial infarction patients and suggest potential mechanisms underlying different clinical scores used to predict death.
[31898016] The emerging roles of lactate as a redox substrate and signaling molecule in adipose tissues.
[31897320] Lactation Ketoacidosis: A case series.
[31863321] Metabolite profiling paradoxically reveals favorable levels of lipids, markers of oxidative stress and unsaturated fatty acids in a diabetes susceptible group of Middle Eastern immigrants.
[31862950] Relationship between gut microbiota and circulating metabolites in population-based cohorts.
[31852859] Identification of disordered metabolic networks in postpartum dairy cows with left displacement of the abomasum through integrated metabolomics and pathway analyses.
[31827206] Plasma metabolomics of early parenteral nutrition followed with enteral nutrition in pancreatic surgery patients.
[31824339] Every-Other-Day Feeding Decreases Glycolytic and Mitochondrial Energy-Producing Potentials in the Brain and Liver of Young Mice.